SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 22,523 Value ($000) $0 Avg Close $17.45 Range $12.99 - $22.73
Q3 2025
Shares 16,908 Value ($000) $0 Avg Close $13.09 Range $8.59 - $17.24
Q2 2025
Shares 17,430 Value ($000) $0 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 87,284 Value ($000) $1 Avg Close $14.10 Range $12.06 - $16.95
Q4 2024
Shares 36,857 Value ($000) $0 Avg Close $17.11 Range $12.40 - $22.50
Q4 2023
Shares 24,659 Value ($000) $1 Avg Close $15.37 Range $11.21 - $21.84
Q2 2022
Shares 11,542 Value ($000) $222 Avg Close $16.66 Range $13.27 - $19.91
Q1 2022
Shares 43,300 Value ($000) $753 Avg Close $16.84 Range $14.56 - $22.27
Q4 2020
Shares 23,958 Value ($000) $533 Avg Close $20.74 Range $13.92 - $27.85
Q3 2020
Shares 37,420 Value ($000) $552 Avg Close $15.24 Range $13.04 - $17.99
Q4 2019
Shares 23,041 Value ($000) $202 Avg Close $7.34 Range $5.35 - $9.47
Q2 2019
Shares 24,550 Value ($000) $229 Avg Close $7.29 Range $4.82 - $9.66
Q1 2019
Shares 15,323 Value ($000) $80 Avg Close $5.70 Range $4.24 - $7.12
Q2 2018
Shares 52,400 Value ($000) $368 Avg Close $9.81 Range $6.61 - $15.20